Testing Protocols Sample Clauses

Testing Protocols. The Parties agree on the design verification, production validation and continuing conformance testing protocols (“Testing Protocols”) that are set forth on Exhibit G, which may be amended, supplemented or restated from time to time during the Term by mutual written agreement of the Parties.
View SourceView Similar (7)
Testing Protocols a. Any drug or alcohol testing shall occur during or immediately after the regular work period of current employees, and shall be deemed time worked for purposes of compensation and benefits for current employees. b. The City shall pay all costs of testing and transportation associated with a test required by the City. c. The information received from drug testing shall be the property of the City. d. Upon City receipt of the test results, Human Resources/Risk Management shall, as soon as practical, notify the person tested, by telephone or in writing, of the test results. e. If the test results are positive, the person tested will be advised of the option to have the split sample tested, the expense to be equally divided between the donor and the City. The option must be exercised within 72 hours of the notification to the employee.
View SourceView Similar (3)
Testing Protocols a. Drug 1. Whenever an employee is required to provide a urine specimen for these testing procedures, the specimen will be divided into two samples at the time of collection in order to facilitate the testing procedures described in this section. The collection facility and the Substance Abuse and Mental Health Services Administration (SAMHSA) certified tester shall follow specimen collection and testing procedures consistent with the HHS Guidelines except as specifically amended herein. 2. The threshold level or cut-off limit and substances shall be as set forth below or as established by HHS and/or SAMHSA. The following levels have been established as of the effective date of this Agreement. However, the levels established by HHS and/or SAMHSA which are in effect as of the date of any given test shall govern Marijuana metabolites (THCA) 2 50 ng/mL 3 THCA 15 ng/mL. Cocaine metabolite (Benzoylecgonine) 150 ng/mL 3 Benzoylecgonine 100 ng/mL. Codeine/Morphine 2,000 ng/mL Codeine Morphine 2,000 ng/mL. 2,000 ng/mL. Hydrocodone/Hydromorphone 300 ng/mL Hydrocodone Hydromorphone 100 ng/mL. 100 ng/mL. Oxycodone/Oxymorphone 100 ng/mL Oxycodone Oxymorphone 100 ng/mL. 100 ng/mL. 6-Acetylmorphine 10 ng/mL 6-Acetylmorphine 10 ng/mL. Phencyclidine 25 ng/mL Phencyclidine 25 ng/mL. Amphetamine/Methamphetamine 500 ng/mL Amphetamine Methamphetamine 250 ng/mL. 250 ng/mL. MDMA 4/MDA 5 500 ng/mL MDMA MDA 250 ng/mL. 250 ng/mL. 1 For grouped analytes (i.e., two or more analytes that are in the same drug class and have the same initial test cutoff): Immunoassay: The test must be calibrated with one analyte from the group identified as the target analyte. The cross-reactivity of the immunoassay to the other analyte(s) within the group must be 80 percent or greater; if not, separate immunoassays must be used for the analytes within the group. Alternate technology: Either one analyte or all analytes from the group must be used for calibration, depending on the technology. At least one analyte with the group must have a concertation equal to or greater than the initial test cutoff or, alternatively, the sum of the analytes present (i.e. equal to or greater than the laboratory’s validate limit of quantification) must be equal to or greater than the initial test cutoff. 2 An immunoassay must be calibrated with the target analyte ∆-9-tetrahydrocannabinos-9carboxylic acid (THCA). 3 Alternate technology (THCA and benzoylecgonine): The confirmatory test cutoff must be used for an alternate...
View SourceView Similar (3)
Testing Protocols. Seattle Children's will collaborate with District to design and carry out testing protocols for Participating Individuals at the District Schools that
View SourceView Similar (2)
Testing Protocols. The minimum testing protocol should include; Colour, clarity and precipitations pH API concentration Sub-visible particle counts Degradation product concentration and an understanding of the degradation mechanism and / or a risk assessment of the properties of the degradation products Additional parameters are to be included where applicable, for example; Moisture loss – by weight (particularly applicable to infusion bags – see storage condition 2 in Table 1 above) Container extractables and leachables Excipient concentrations.
View Source
Testing Protocols. The testing procedures for drugs will be carried out in accordance with AS/NZS Standard 4308:2008 (and updates) “Procedures for Specimen Collection, and the Detection and Quantitation of Drugs of Abuse in Urine.” Details of testing procedures are provided in Appendix 2. Testing for breath alcohol will be carried out using a device which complies with AS 3547-1997/ Amendment 1-2000 (Type 2) “Breath Alcohol testing devices for personal use.” Details of testing procedures are provided in Appendix 1. Drug Testing will be carried out by an independent third party as approved by KiwiRail. Alcohol Testing will be carried out by trained testers.
View Source
Testing Protocols. The procedures for random drug tests required pursuant to this Policy are as follows:
View Source
Testing Protocols 
View SourceView Similar (9)

Related to Testing Protocols

  • Protocols Each party hereby agrees that the inclusion of additional protocols may be required to make this Agreement specific. All such protocols shall be negotiated, determined and agreed upon by both parties hereto.

  • Protocol The attached Protocol shall be an integral part of this Agreement.

  • Testing Procedures The following test procedure shall apply to all urine tests administered to bargaining unit employees: a. Urine specimens shall be collected at the approved laboratory as stated below in section (e), or at an accredited medical facility when necessary after an accident. b. The employee shall not be observed when the urine specimen is given. c. All specimen containers, vials or bags used to transport the samples shall be sealed with evidence tape and labeled in the presence of the employee. d. The testing shall be done by another approved laboratory. e. The employer shall choose the testing/collection facility to be utilized for toxicology testing on a yearly basis. f. The following standards shall be used to determine what levels of detected substances shall be considered positive. Note: - These are current levels subject to change by Federally Mandated Regulations. Current Federal Regulations shall be controlling in case of change or conflict: DRUG SCREENING TEST CONFIRMATION Amphetamines 500 ng/ml Amphetamine 250 ng/ml GC-MS Marijuana Metabolites 50 ng/▇▇ ▇▇▇▇▇-THC 15 ng/ml GC-MS Cocaine Metabolites 150 ng/ml Metabolites 100 ng/ml GC-MS Opiates Morphine 2,000 ng/ml 2,000 ng/ml GC-MS PCP 25 ng/ml PCP 25 ng/ml GC-MS MDMA 500 ng/ml 250 ng/ml Alcohol .08 Breath .04 Breath – Employees with CDL .02 - .039 Breath - Employees with CDL will be removed from service for 24 hrs. g. Tests which are below the levels set forth above shall be determined as negative. If test results are negative, all non-required documentation regarding supervisors' observations and testing will be destroyed. h. At the time the urine specimen is collected two samples will be taken. One sample will be sent to the laboratory to be tested at the employer's expense. If the first sample tests positive then upon written request by the employee within twenty-four

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • Signaling protocol 4.1.3.1 SS7 Signaling is AT&T-21STATE’s preferred method for signaling. Where MF signaling is currently used, the Parties agree to use their best efforts to convert to SS7. If SS7 services are provided by AT&T-21STATE, they will be provided in accordance with the provisions of the applicable access tariffs. 4.1.3.2 Where MF signaling is currently used, the Parties agree to interconnect their networks using MF or dual tone MF (DTMF) signaling, subject to availability at the End Office Switch or Tandem Switch at which Interconnection occurs. The Parties acknowledge that the use of MF signaling may not be optimal. AT&T-21STATE will not be responsible for correcting any undesirable characteristics, service problems or performance problems that are associated with MF/SS7 inter-working or the signaling protocol required for Interconnection with CLEC employing MF signaling.